Determination of optimal immunohistochemistry (IHC) panel for classification of esophageal tumours - A retrospective analysis and review of literature
Journal Title: Medpulse International Journal of Pathology - Year 2019, Vol 10, Issue 1
Abstract
Context: Histological classification of Esophageal tumors in small endoscopic biopsies based on morphologic criteria alone is difficult due to scant cellularity and biopsy artifacts, necessitating the use of ancillary techniques like IHC. Aims: To analyse the role of immunohistochemistry (IHC) in the classification of esophageal tumors with an optimal panel of markers (p63, Ck 5/6, CK-7, CDX2 and MUC5AC). Settings and Design: This was a retrospective study done at the Department of Pathology, Kamineni Institute of Medical Sciences, Narketpally from January 2014 to October 2018. Material and Methods: Endoscopic biopsies from patients with 50 SCCs, 22 Adenocarcinomas and 25 poorly differentiated tumors were stained with IHC markers and their immunoreactivity was scored and documented. Statistical analysis used: Sensitivity, Specificity, Positive Predictive value (PPV), Negative Predictive value (NPV) and Accuracy of individual markers and their combination were calculated and documented. Results: In our study all cases of Squamous cell carcinoma were immunoreactive for p 63 and CK 5/6, with 4 + reactivity (in greater than 75% of tumor cells) observed in 48 cases (96%) for p63 and 46 cases (92%) for CK 5/6. The combination of p63 and cytokeratin 5/6 is highly sensitive, reasonably specific with high positive predictive and accuracy value for diagnosis of esophageal squamous cell carcinoma. In Esophageal adenocarcinomas strong immunoreactivity (3+,4+) for CK 7 was observed in 18 cases (81.8%), for MUC5AC in 17 cases (77.3%) and for CDX2 in 13 cases (59.1%). CK7(87.1%) was the most sensitive marker and MUC5AC had superior specificity (91.2%). Both markers in combination supplemented each other with improved attributes and formed a potent combination for securing a diagnosis of adenocarcinoma. Results of IHC on the subset of poorly differentiated carcinoma reflected same attributes as observed in individual markers/combination for squamous Cell Carcinoma and adenocarcinoma. Conclusions: First-line two marker panel of p63 and cytokeratin 5/6 is highly sensitive and specific for distinguishing squamous cell carcinoma from adenocarcinoma and in classification of poorly differentiated tumours. The presence of MUC5AC and CK 7 immunoreactivity may help establish the diagnosis of adenocarcinoma in the setting of negative/diminished/focal weak staining with p63 and cytokeratin 5/6
Authors and Affiliations
Srinivas DD Gubbala, Sridevi Mattaparti
Keywords
Related Articles
- EP ID EP590585
- DOI 10.26611/1051012
- Views 76
- Downloads 0
Distribution of ABO, rhesus blood groups and transfusion transmitted diseases in a blood bank of a tertiary care hospital: A one year study
Background: The study of the distribution of ABO blood group and rhesus blood group is significant for the genetic studies as well as for medico legal issues and for the smooth and efficient working of the blood bank of...
A clinico-pathological study of anemia’s in geriatric age group
Background: Anemia in the elderly is a major health problem in India and many parts of the world, since it signifies an underlying disease and is associated with poor clinical outcome like increased morbidity and poor he...
Sero-prevalence and trends of transfusion transmitted infections among blood donors at blood bank, government general hospital, Mahabubnagar district, Telangana
Background: Blood transfusion is a life-saving therapeutic intervention and millions of lives are saved each year globally through this procedure. However, blood transfusions are associated with certain risks which can l...
Clinico-etiological profile of the neonates with thrombocytopenia admitted to NICU in a rural hospital - A cross sectional study
Background: The most common haematological abnormality seen in neonates admitted to neonatal intensive care unit (NICU) is thrombocytopenia. Even though thrombocytopenia is more prevalent many a times it is not treated p...
Diagnostic and prognostic value of AgNOR study in radiotherapy treated squamous cell carcinoma of the cervix
Background: Carcinoma Cervix is the second most common cancer worldwide especially in peri-menopausal period. AgNOR proved to be a sensitive marker to predict the prognosis of the patient treated with radiotherapy. The p...